Study on the effect of phototherapy for inhibition of symptoms associated with allergic rhinitis

Previous published work has indicated that treatment of the inside of the nose with certain wavelengths of light can reduce the symptoms of allergic rhinitis.The objective of the study was to compare the efficacy of the phototherapy device on the relief of a range of symptoms provoked by indoor and outdoor allergens.A phototherapy emits visible light (mUV/VIS) and infrared light, and was compared to a placebo device which did not emit light on two groups of allergic rhinitis sufferers.Rhinophototherapy improved nasal symptoms of allergic rhinitis arising from exposure to indoor and outdoor allergens.The difference in the intensity of symptoms scored at the baseline, and at the final visit for the group using the photoperiod device was significantly lower.The device could potentially help improve the quality of life for allergy sufferers.Phototherapy may be suitable for sufferers either as a replacement therapy or used alongside traditional medication.medication that they take, or who find that medication is not sufficient to control their symptoms.One possible method in reducing the dosages of pharmacological products may be to combine their usage with other methods.Previous published work has indicated that treatment of the inside of the nose with certain wavelengths of light can reduce the symptoms of allergic rhinitis (5).Early studies looked at the effects on perennial / persistent rhinitis and more recent studies (6,7) have looked at the effect on seasonal / intermittent allergic rhinitis.Phototherapy has an immunosuppressive effect and is widely used for the treatment of immune mediated skin diseases.Phototherapy devices are able to inhibit immediate type hypersensitivity reaction in the skin.Intranasal phototherapy is an approach more suitable for treatment of allergic rhinitis.In two open studies, 308 nm excimer laser and topical PUVA therapy efficiently inhibited clinical symptoms of allergic rhinitis (5).In a randomized, double-blind study combined low dose UVB,